-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Lowers Price Target to $696

Benzinga·07/07/2026 15:45:30
Listen to the news
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and lowers the price target from $707 to $696.